Cure MSA

Country specific patient information


Principal investigator:

PD Dr. Karla Eggert

Philipps-University Marburg
Department of Neurology
Rudolf-Bultmann-Straße 8
D-35033 Marburg


Expertise of the participating organisation:

The group has a strong clinical background in diagnosis, clinical differential diagnosis and treatment of Parkinson and MSA-Patients. Prof. Oertel and his group have long-term experience in research on neuroprotective agents, pharmacology, neuroimaging , autonomic testing, and pharmacoeconomics. The participating organisation will provide the network system for electronic data management.

Recent publications relevant to the EMSA-SG:


Oertel W, Poewe W, Wolters E, De Deyn PP, Emre M, Kirsch C, et al. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug Saf 2008; 31: 79-94.


Stamelou M, Reuss A, Pilatus U, Magerkurth J, Niklowitz P, Eggert KM, et al. Short-term effects of coenzyme Q(10) in progressive supranuclear palsy: A randomized, placebo-controlled trial. Mov Disord 2008.


Oertel WH, Wolters E, Sampaio C, Gimenez-Roldan S, Bergamasco B, Dujardin M, et al. Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study. Mov Disord 2006; 21: 343-53.


Meindorfner C, Korner Y, Moller JC, Stiasny-Kolster K, Oertel WH, Kruger HP. Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005; 20: 832-42.


Spottke AE, Reuter M, Machat O, Bornschein B, von Campenhausen S, Berger K, et al. Cost of illness and its predictors for Parkinson's disease in Germany. Pharmacoeconomics 2005; 23: 817-36.


Oertel WH, Wachter T, Quinn NP, Ulm G, Brandstadter D. Reduced genital sensitivity in female patients with multiple system atrophy of parkinsonian type. Mov Disord 2003; 18: 430-2.